IP Library Patent Application 19071413
Patent Application
App. No. 19/071,413

UTERINE HEMORRHAGE CONTROLLING SYSTEM AND METHOD

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
19/071,413
Abstract

An embodiment of a uterine hemorrhage controlling system comprises a suction module including a suction end coupleable to a pump by a connecting tube, and a sealing module coupled to the suction module. The system may further comprise the pump and a filter coupled to the suction module. A uterine hemorrhage controlling method comprises: shielding a suction module that has been delivered into a uterus; sealing an entrance into the uterus while the suction module is situated within the uterus; applying a negative pressure within the uterus upon activation of a pump; and maintaining the negative pressure within the uterus to induce uterine contraction. The method may further comprise delivering the suction module into the uterus; transmitting bodily fluids, out of the uterus through the suction module, and filtering the bodily fluids.

Claims (12)

1 . A method for contracting a uterus of a patient to mitigate uterine hemorrhaging, the method comprising:

positioning a uterine contractile apparatus having a set of flexible vacuum members coupled to a connecting tube within the uterus so that a sealing bladder surrounding the connecting tube of the uterine contractile apparatus is near an entrance of the uterus at an intravaginal canal location of the patient;

creating a seal configured to enable maintenance of a vacuum within the uterus, upon pumping a fluid through an inflation tube coupled to the sealing bladder into the sealing bladder to inflate the sealing bladder;

drawing a vacuum through a perforated outer surface of each of the set of vacuum members and through the connecting tube; and

contracting the uterus in order to counteract uterine atony, upon transmission of bodily fluids from the uterus through the set of vacuum members and the connecting tube, thereby mitigating uterine hemorrhaging.

2 . The method of claim 1 further comprising: maintaining the vacuum by way of the connecting tube and the set of vacuum members to contract the uterus until a rate of postpartum hemorrhaging is less than 5 milliliters per minute.

3 . The method of claim 1 further comprising: maintaining the vacuum by way of the connecting tube and the set of vacuum members to contract the uterus for at least 10 seconds.

4 . The method of claim 1 further comprising: maintaining the set of vacuum members within the uterus for at least 30 minutes.

5 . The method of claim 1 further comprising: transitioning between an inflated and a deflated state after positioning the sealing bladder near the entrance of the uterus.

6 . The method of claim 1 further comprising: filtering the bodily fluids removed from the uterus.

7 . The method of claim 1 wherein the internal pressure of the sealing bladder after the pumping is between about 0.1 to 5 psi.

8 . The method of claim 1 wherein the vacuum created is between 0.1 to 3 psi.

Assignments (1)
SECURITY INTEREST Recorded Feb 27, 2026
From: ALYDIA HEALTH, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 073924/0283 →